market refers to the sector of the life sciences industry that focuses on the use of advanced imaging and analysis techniques to study and analyze cellular processes and biological phenomena on a large scale. HCS involves the automated imaging and quantitative analysis of cells or organisms using technologies such as fluorescence Microscopy, automated liquid handling, and sophisticated image analysis software.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/europe-high-content-screening-market
Data Bridge Market Research analyses that the Europe High Content Screening Market is expected to grow at a CAGR of 6.8% from 2023 to 2030 and is expected to reach USD 1,057,169.94 thousand by 2030. The growing number of CROs providing HCS services is expected to propel the growth of the market.
Key Findings of the Study
Advancement in Imaging Technologies Used for High Content Screening
Imaging technologies have been at the forefront of High Content Screening (HCS), enabling researchers to visualize and analyze cellular processes with unprecedented detail and precision. In addition to high-resolution imaging, there have been significant improvements in imaging speed and throughput. HCS helps in the analysis of a large number of samples, often in high-throughput formats. Imaging technologies have evolved to provide faster acquisition times, enabling researchers to analyze large datasets in a shorter period. High-speed imaging techniques, such as spinning disk confocal microscopy and light-sheet microscopy, allow for rapid image acquisition without compromising image quality, facilitating efficient screening workflows and data analysis.
Over the years, significant advancements have been made in imaging modalities, microscopy techniques, and imaging analysis tools, transforming the landscape of HCS and driving its market expansion.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020 )
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Product Type (Instruments, Consumables, Softwares, Services and Accessories), Application (Primary and Secondary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling and Other Applications), Technology (Microscopy, Flow Cytometry, Immunohistochemistry, Extracellular Matrix Based Scaffold, ELISA, Western Blotting and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Laboratories, Academic and Government Institutes, Others) Distribution Channel (Direct Tenders, Retail Sales)
|
|
Countries Covered
|
Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, and Rest of Europe
|
|
Market Players Covered
|
BD (U.S.), Merck KGaA (Germany), Corning Incorporated (U.S.), Carl Zeiss AG (Germany), Sartorius AG (Germany), Zifo RnD Solutions (India), Axxam S.p.A. (Italy), Molecular Devices, LLC. (Subsidiary of Danaher Corporation) (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Yokogawa Electric Corporation (Japan), Sysmex Corporation (Japan), Genedata AG (Switzerland), Miltenyi Biotec (Germany), Aligned Genetics, Inc. (South Korea) and among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The Europe high content screening market is categorized into five notable segments such as product type, application, technology, end user, and distribution channel.
- On the basis of product type, the market is segmented into instruments, consumables, softwares, services, accessories.
In 2023, the instruments segment is expected to dominate the Europe high content screening market
In 2023, the instruments segment is expected to dominate the market with a 28.75% market share, due to increasing advancement in imaging technologies used for High Content Screening (HCS).
- On the basis of application, the market is segmented into primary and secondary screening, target identification & validation, toxicity studies, compound profiling and other applications.
In 2023, the primary and secondary screening segment is expected to dominate the Europe high content screening market
In 2023, the primary and secondary screening segment is expected to dominate the market with 35.26% market share, due to its ability to enable the identification, validation, and characterization of potential drugs, contributing to the drug discovery process.
- On the basis of technology, the market is segmented into microscopy, Flow Cytometry, extracellular matrix based scaffold, western blotting, ELISA, immunohistochemistry and others. In 2023, the microscopy segment is expected to dominate the market with a 24.85%.
- On the basis of end user, the market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations, laboratories and others. In 2023, the microscopy segment is expected to dominate the market with a 35.94% market share.
- On the basis of distribution channel, the market is segmented into direct tenders and retail sales. In 2023, the direct tenders segment is expected to dominate the market with a 63.85% market share.
Major Players
Data Bridge Market Research analyzes BD (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer Inc.(U.S.), Yokogawa Electric Corporation (Japan), Molecular Devices, LLC. (Subsidiary of Danaher Corporation) (U.S.) as the major market players in the market.
Market Developments
- In October 2022, BD (Becton, Dickinson and Company) a leading Europe medical technology company, and Magnolia Medical Technologies, Inc., announced a co-exclusive commercial agreement aimed at helping U.S. hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes. This has helped the company to get connected to various vendors and get established Europely.
- In February 2023, PerkinElmer Inc. launched the EnVision Nexus system, its fastest and most sensitive multimode plate reader to date, designed for demanding High-Throughput Screening (HTS) applications and to accelerate drug discovery efforts. This product launch has helped the company in its product portfolio expansion. This helped the company to expand its clinical diagnostics business across various regions in the world and helped to increase the Europe presence in the market.
- In February 2023, Agilent Technologies, Inc. announced the release of new NovoExpress software that introduces integrated compliance tools for NovoCyte flow cytometer systems. This helps the company strengthen its product portfolio in the market.
- In January 2021, Corning Incorporated will highlight its latest technologies that support the advancement of 3D cell culture, automation, and drug discovery at this year's virtual Society for Laboratory Automation and Screening (SLAS) conference. This will help the company to expand its product portfolio.
- In May 2023, Sysmex Corporation announced that it would launch its Clinical Flow Cytometry System Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other related products in Japan, following the launch in North America, Europe, and Asia-Pacific regions. This product launch helps the company in product portfolio expansion.
Regional Analysis
Geographically, the country covered in the market report is Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, and Rest of Europe.
Germany is the fastest-growing and dominant country in the market during the forecast period 2023 -2030
Germany is expected to dominate the market because of the higher level of investments by various manufacturers and increasing technological advancements in the region.
As per Data Bridge Market Research analysis:
For more detailed information about the high content screening market, click here – https://www.databridgemarketresearch.com/ar/reports/europe-high-content-screening-market
